| Literature DB >> 35168559 |
Gobong Choi1, Jongbum Jeon1,2,3, Hyunjun Lee4, Shenxian Zhou4, Yong-Hwan Lee5,6,7,8.
Abstract
BACKGROUND: Long non-coding RNAs (lncRNAs) play essential roles in developmental processes and disease development at the transcriptional and post-transcriptional levels across diverse taxa. However, only few studies have profiled fungal lncRNAs in a genome-wide manner during host infection.Entities:
Keywords: Host infection; Long non-coding RNA; Magnaporthe oryzae; RNA-seq; Transcriptional regulation
Mesh:
Substances:
Year: 2022 PMID: 35168559 PMCID: PMC8845233 DOI: 10.1186/s12864-022-08380-4
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Schematic pipeline for identification of lncRNAs in M. oryzae. A Bioinformatic pipeline for lncRNA identification using RNA-seq data. CPAT, Coding Potential Assessment Tool. B Number of predicted transcripts. C Number of lncRNAs by different classes
Classification of lncRNAs in M. oryzae
| Class of transcripts | Number of novel transcripts | Number of lncRNAs |
|---|---|---|
| Sense transcript | 8,444 | 322 |
| Antisense transcript | 2,636 | 1,286 |
| Intergenic transcript | 2,876 | 980 |
| Intronic transcript | 22 | 13 |
Fig. 2Genomic features of M. oryzae lncRNAs. A Distributions of mRNAs (bluish green) and lncRNAs (red) across chromosomes. B Distribution of transcript lengths. C Distribution of exon numbers per transcript. D GC ratio (%). The Wilcoxon–Mann–Whitney test confirmed a significant difference in GC ratio between the two groups. *** p < 0.001
Fig. 3LncRNA expression level and pattern. A, B Expression heatmaps of 9,410 mRNAs and 2,601 lncRNAs, respectively. Z-score normalization was applied to FPKM values across stages. C Boxplot of mRNA (bluish green) and lncRNA (red) expression patterns across developmental and infection stages. D Density plot of transcript stage specificity over six stages. τ (Tau) is used as a stage specificity index. The index varies from 0 (consistently expressed transcripts) to 1 (perfectly stage-specific transcripts). The Wilcoxon–Mann–Whitney test confirmed a significant difference in tau distribution between the two groups. *** p < 0.001
Fig. 4Infection stage-specific lncRNAs and their target genes. A Numbers of lncRNAs according to expression pattern. Red spots indicate an expression peak at each stage. B Expression heatmap of infection-specifically expressed lncRNAs and their CAZyme target genes. FPKM values were normalized across conditions based on Z-scores. Normalizations of mRNAs and lncRNAs were performed separately. * indicates a functionally characterized xylanase. CAZyme, Carbohydrate-active enzyme
Target genes of infection specifically-expressed lncRNAs matched to genes from PHI-base
| ISEL | Mode of action | Target gene | Description |
|---|---|---|---|
| MSTRG.14853.1 | Trans | MoCDIP4 | Plant cell death inducer |
| MSTRG.8963.1 | Trans | ||
| MSTRG.14634.1 | Trans | ACE1 | Polyketide synthase |
| MSTRG.10882.1 | Trans | MoSNF1 | AMP-activated protein kinase |
| MSTRG.5151.2 | Cis | MET12 | Methylenetetrahydrofolate reductase |
| MSTRG.12783.1 | Trans | MoSOM1 | Transcriptional regulator |
| MSTRG.14270.3 | Cis/trans | MoSSK1 | Response regulator |
| MSTRG.1779.3 | Cis | MoCOD1 | Zn2Cys6 transcription factor |
| MSTRG.8913.3 | Trans | MoPER1 | GPI anchored-related gene |
| MSTRG.14270.1 | Trans | MGG_08331T0 | Endo-1,4-beta-xylanase |
| MSTRG.14270.2 | Trans | ||
| MSTRG.14853.1 | Trans | ||
| MSTRG.4487.2 | Trans | ||
| MSTRG.4487.3 | Trans | ||
| MSTRG.8648.1 | Trans | ||
| MSTRG.8648.2 | Trans | ||
| MSTRG.8648.1 | Trans | MGG_08424T0 | Endo-1,4-beta-xylanase |
| MSTRG.8648.2 | Trans | ||
| MSTRG.8655.2 | Trans | ||
| MSTRG.14853.1 | Trans | MPG1 | Hydrophobin |
| MSTRG.8407.2 | Trans | ||
| MSTRG.8648.1 | Trans | ||
| MSTRG.8648.2 | Trans | ||
| MSTRG.14853.1 | Trans | MGG_10730T0 | Na+-ATPase |
| MSTRG.13745.1 | Trans | MoLDS1 | Animal peroxidase |
| MSTRG.2819.1 | Trans | SSM2 | Non-ribosomal peptide synthetase |
| MSTRG.12783.1 | Trans | MGG_15019T0 | Peroxisomal copper amine oxidase |
| MSTRG.10882.1 | Cis | MoRGS4 | G-protein signaling regulator |
| MSTRG.8407.2 | Cis | Pmc1 | Vacuolar membrane-located Ca2+ pump |
| MSTRG.13998.6 | Trans | ||
| MSTRG.1930.1 | Trans | MST12 | STE-like transcription factor |
| MSTRG.1930.3 | Trans | ||
| MSTRG.8389.1 | Cis | XYL1 | Endo-1,4-beta-xylanase |
| MSTRG.13915.1 | Trans | XYL-6 | Endo-1,4-beta-xylanase |
| MSTRG.10882.1 | Trans | FZC87 | Zn2Cys6 transcription factor |
| MSTRG.14853.1 | Trans | FZC12 | Zn2Cys6 transcription factor |
| MSTRG.1930.1 | Trans | FZC42 | Zn2Cys6 transcription factor |
| MSTRG.1930.3 | Trans |
Fig. 5Validation of lncRNA production. Validation of lncRNAs was performed with strand-specific RT-PCR. Templates were cDNAs synthesized from the RNA of mycelia, 24 h post-inoculation (hpi), 48 hpi, and 72 hpi on infected rice leaves. * indicates an antisense lncRNA. # indicates an intergenic lncRNA. β-tubulin gene was used as a control. Full-length gels are presented in Fig. S2 (Additional file 5)